The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiplex analysis of the immune environment before and after neoadjuvant durvalumab as a prognostic factor in resectable non-small cell lung cancer (NSCLC) in the IFCT-1601 IONESCO phase 2 trial.
 
Diane Damotte
No Relationships to Disclose
 
Yoan Velut
No Relationships to Disclose
 
Barbara Burroni
No Relationships to Disclose
 
Gary Birsen
No Relationships to Disclose
 
Julien Lavergne
No Relationships to Disclose
 
Audrey Mansuet-Lupo
No Relationships to Disclose
 
Isabelle Cremer
No Relationships to Disclose
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; Hengrui Therapeutics; Lilly/ImClone; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Jacques Cadranel
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme
Consulting or Advisory Role - Abbvie (Inst); Amgen; AstraZeneca/MedImmune; Janssen; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi (Inst); Takeda
Research Funding - Pfizer (Inst)
 
Gerard Zalcman
No Relationships to Disclose
 
Radj Gervais
No Relationships to Disclose
 
Gaelle Jeannin
No Relationships to Disclose
 
Olivier Molinier
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Sanofi/Regeneron; TEKADA
Travel, Accommodations, Expenses - AstraZeneca; Janssen; SANOFI/REGENERON; Takeda
 
Thomas Egenod
No Relationships to Disclose
 
Olivier Carre
No Relationships to Disclose
 
Celia Berndt
No Relationships to Disclose
 
Alexandra Langlais
No Relationships to Disclose
 
Franck Morin
No Relationships to Disclose
 
Virginie Westeel
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Ipsen
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Pfizer; Lilly; MSD
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myers Squibb; Roche; Sanofi
 
Marie Wislez
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Roche; Sanofi
Speakers' Bureau - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Roche; Sanofi
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Roche